1.
Danilenko LM. Experimental Approaches to the Assessment of Potential Cardioprotective Means with Doxorubicin-Associated Cardiomyopathy. AJP [Internet]. 2019 Feb. 4 [cited 2024 Dec. 4];12(04). Available from: http://asiapharmaceutics.info/index.php/ajp/article/view/2943